Table 3.
Findings | Prognosis | P | |
---|---|---|---|
Dead due to ILD N = 3 | Alive N = 24 | ||
Enlarged capillary | 1.75 (0.8–2) | 1.2 (0.35–2.13) | 0.79 |
Giant capillary | 0.75 (0–1.33) | 0 (0–0.19) | 0.10 |
Microhemorrhage | 0.8 (0.75–2.5) | 0.33 (0.05–0.5) | 0.02* |
Capillary loss | 1.8 (1.5–1.83) | 1.41(0.62–1.75) | 0.15 |
Capillary disorganization | 1.2 (1–1.5) | 0.38 (0.10–0.79) | 0.04* |
Neoangiogenesis | 0.83 (0.5–1.6) | 0 (0–0.38) | 0.02* |
Bushy capillary | 0.33 (0.25–0.8) | 0 (0–0.22) | 0.03* |
Bizzare capillary | 0.5 (0.25–0.8) | 0 (0–0.25) | 0.03* |
Cross capillary | 1.0 (0.5–1.0) | 0.69 (0.5–1.18) | 1.00 |
Tortuous capillary | 0.6 (0.17–1) | 1.2 (0.53–1.5) | 0.16 |
DM, dermatomyositis; ILD, interstitial lung disease.
The laboratory markers are presented as the median (interquartile range). The P-values were estimated using Wilcoxon rank sum test. *P < 0.05.